Skip to main content
CA

Cardiol Therapeutics

Oakville, Canada
Last funding
$7.0M
Post-IPO EquitySep 2026

Cardiol Therapeutics develops innovative cannabidiol medicines for heart disease.

Backed byRaymond JamesCanaccord Genuity GroupAlbaCore CapitalEchelon Wealth Partners

About Cardiol Therapeutics

How much funding has Cardiol Therapeutics raised?

Cardiol Therapeutics has raised $7.0M in total funding. The most recent round was Post-IPO Equity. The last funding was announced in September 2026.

Who are Cardiol Therapeutics's investors?

Cardiol Therapeutics's investors include Raymond James, Canaccord Genuity Group, AlbaCore Capital, Echelon Wealth Partners.

Where is Cardiol Therapeutics headquartered?

Cardiol Therapeutics is headquartered in Oakville, Canada.

What does Cardiol Therapeutics do?

Cardiol Therapeutics develops innovative cannabidiol medicines for heart disease.

What stage is Cardiol Therapeutics at?

Cardiol Therapeutics is at the Post-IPO Equity stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .

MLA
"Cardiol Therapeutics — Funding & Investors." VCBacked, September 16, 2026, https://www.vcbacked.co/company/cardiol-therapeutics. Accessed November 14, 2026.
APA
VCBacked. (2026). Cardiol Therapeutics — Funding & Investors. Retrieved November 14, 2026, from https://www.vcbacked.co/company/cardiol-therapeutics
Wikipedia (cite web)
{{cite web |title=Cardiol Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/cardiol-therapeutics |website=VCBacked |access-date=November 14, 2026}}

Profile data sourced and verified per the VCbacked methodology · Last funding round dated

Work at Cardiol Therapeutics? Request a listing update

Founder contacts
m***@cardiolrx.com
linkedin.com/in/●●●●●●
Emails, phones & LinkedIn · 41,000+ verified contacts
Get instant access →